Study Stopped
Participant enrollment was hindered by the COVID-19 pandemic and the study was ultimately terminated.
Changing Developmental Trajectories Through Early Treatment
Autism Center of Excellence: Project 3 - Changing Developmental Trajectories Through Early Treatment
2 other identifiers
interventional
33
1 country
1
Brief Summary
The major objective of this research protocol is to directly compare two parent intervention conditions of Early Social Interaction (ESI) for 9 months on developmental trajectories of infants showing early risk for Autism Spectrum Disorder (ASD). Participants will be randomized to receive an information, education and support group (Group) ESI intervention offered weekly, or a parent-implemented intervention (Individual) ESI intervention offered in twice-weekly, in combination with the Group ESI intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2013
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2013
CompletedFirst Submitted
Initial submission to the registry
November 5, 2013
CompletedFirst Posted
Study publicly available on registry
November 15, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 26, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
November 26, 2019
CompletedResults Posted
Study results publicly available
June 9, 2023
CompletedJune 9, 2023
May 1, 2023
6.6 years
November 5, 2013
February 27, 2023
May 12, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Communication and Symbolic Behavior Scales (CSBS) Score
Social communication skills were measured with the Communication and Symbolic Behavior Scales (CSBS) Behavior Sample. Interactions between the child and caregiver were videotaped and later converted to scores. The standardized total score has a mean of 100 and standard deviation of 15. Scores below 100 indicate below average performance with the social, speech, and symbolic composites.
Baseline (12 months of age, prior to treatment), 15, 21, and 24 months of age
Autism Diagnostic Observation Schedule (ADOS) Score
Autism symptoms were measured with the Autism Diagnostic Observation Schedule, Second Edition which is the best gold standard diagnostic measure of ASD. The revised algorithms forming Social-Affect and Restricted Repetitive Behavior ratings of autism symptoms were used. A total of score of 1 to 3 indicates no signs of autism, a score of 4 or 5 suggests that the child may have autism spectrum disorder, while a score of 6 to 10 is indicative of autism.
15, 24, and 36 months of age
Mullen Scales of Early Learning (MSEL) Score
The Mullen Scales of Early Learning (MSEL) measures developmental level with standardized scores in five domains: Visual Reception, Receptive Language, Expressive Language, Fine Motor Skills, and Gross Motor Skills. Domain scores are represented in T-scores, with a mean of 50 and standard deviation of 10. A Verbal Composite score is calculated by averaging T-scores of the domains for Receptive and Expressive Language. A Nonverbal Composite score is calculated by averaging T-scores for Visual Reception and Fine Motor domains. Scores below 50 indicate below average performance.
Baseline (12 months of age, prior to treatment), 24, and 36 months of age
Vineland Adaptive Behavior Scales, Second Edition (Vineland II) Score
The Vineland II assesses adaptive behavior by providing a standard score in four domains of Communication, Daily Living Skills, Socialization, and Motor Skills. Domain scores and the Adaptive Behavior Composite score are standardized with a mean of 100 with a standard deviation of 15. Scores less than 100 indicate below average performance.
Baseline (12 months of age, prior to treatment), 24, and 36 months of age
Other Outcomes (1)
Expressive Language Phase
Baseline (12 months of age, prior to treatment), 15, 21, 24, and 36 months of age
Study Arms (2)
Group-ESI
ACTIVE COMPARATORInfants 12 months of age at risk of developing ASD who are randomized to receive the Group-ESI intervention for 9 months.
Individual-ESI plus Group-ESI
EXPERIMENTALInfants 12 months of age at risk of developing ASD who are randomized to receive Individual-ESI intervention in addition to the Group-ESI intervention for 9 months.
Interventions
The Group-ESI intervention consists of weekly small group meetings where families receive information about social communication, emotional regulation, play development, and behavioral challenges in toddler playgroups in a relaxed, supportive, child-friendly setting that provides the opportunity to talk with a professional and meet other parents.
The Individual-ESI intervention consists of twice-weekly home-based individualized coaching sessions. Parents learn how to support their child's communication, social, and play skills in everyday routines, activities, and places. Individual-ESI begins with an initial home visit, followed by a month of program planning, 6 months of intervention implementation, and 2 months of generalization. During generalization, the clinician meets with the family in a variety of community settings to teach the parent how to implement strategies in new settings.
Eligibility Criteria
You may qualify if:
- Participants are recruited from the Emory Autism Center of Excellence Center from a pool of younger siblings who are at high or low risk of developing ASD
- For high-risk infants, a positive screen on 2 of 4 screening measures indicating the presence of diagnostic features of ASD by 12 months of age
- For low-risk infants will be a positive screen on 3 of 4 screening measures
- Families agree to twice monthly play group sessions for 9 months and 2-3 intervention sessions per week for 9 months (usually within work-day hours)
You may not qualify if:
- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Emory Universitylead
- National Institute of Mental Health (NIMH)collaborator
Study Sites (1)
Marcus Autism Center
Atlanta, Georgia, 30329, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Nathan Call, PhD
- Organization
- Emory University
Study Officials
- PRINCIPAL INVESTIGATOR
Nathan Call, PhD
Emory University, Marcus Autism Center, Children's Healthcare of Atlanta
- STUDY DIRECTOR
Amy Wetherby, Ph.D.
Florida State University
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
November 5, 2013
First Posted
November 15, 2013
Study Start
May 1, 2013
Primary Completion
November 26, 2019
Study Completion
November 26, 2019
Last Updated
June 9, 2023
Results First Posted
June 9, 2023
Record last verified: 2023-05
Data Sharing
- IPD Sharing
- Will not share